Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance. DBLG2 received authorization as a Class II interoperable automated glycemic controller (i-AGC). Clearance validates the algorithm’s interoperability and could bring more choice to people with diabetes, the company said on LinkedIn. It marks the latest milestone for the company’s […]
Diabetes
Medtronic Diabetes unit MiniMed files for IPO
Medtronic (NYSE:MDT) announced today that its MiniMed Diabetes business filed with the SEC for a proposed initial public offering (IPO). The medtech giant said MiniMed filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC). It expects to complete the separation from Medtronic through a series of capital markets transactions. […]
Tandem launches t:slim mobile app in Canada
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its t:slim mobile application for Android and iOS users in Canada. San Diego-based Tandem’s t:slim mobile app connects to the company’s t:slim X2 automated insulin delivery system. It enables users to deliver a bolus from their compatible smartphone. They can also wirelessly upload pump data to […]
GlucoModicum unveils Sofio needle-free CGM
GlucoModicum today unveiled Sofio, which it labels the world’s first needle-free glucose monitor based on magneto-hydrodynamics (MHD). MHD technology draws micro-samples of interstitial fluid through the skin. It measures glucose with established electrochemical sensor technology. The single-day sensor system delivers a periodic, personalized monitoring alternative to standard continuous glucose monitor (CGM) devices. Helsinki, Finland-based GlucoModicum’s […]
Medtronic rolls out MiniMed campaign for launch with Instinct sensor made by Abbott
Medtronic (NYSE:MDT) announced the launch of its “Own It” campaign for the rollout of its MiniMed 780G system and Instinct sensor made by Abbott. The campaign aims to bring awareness to the now available system that “works quietly in the background” while people with type 1 diabetes can go about their daily lives. Medtronic (soon […]
Abbott launches Lingo OTC CGM in Walgreens
Abbott (NYSE:ABT) announced today that it made its Lingo over-the-counter continuous glucose monitor (CGM) available at Walgreens. People can purchase the Lingo biosensor both in Walgreens brick-and-mortar stores and online. This marks the latest expansion for Lingo as it penetrates different markets, starting with a launch through Amazon as its first retail agreement for the device earlier […]
Insulet expands Pod recycling program across U.S.
Insulet (Nasdaq:PODD) announced today that it expanded its U.S. Pod recycling program, now making it available to all U.S. customers. The Pod recycling program, offered at no cost to customers, enables users to request a recycling kit online. This allows them to return their used Omnipods. Insulet then decontaminates the returned Pods before transporting them […]
Medtrum introduces 300-unit tubeless insulin pump
Medtrum today unveiled the 300-unit version of its TouchCare Nano tubeless automated insulin delivery patch pump. The China-based company took to LinkedIn to announce the advancement: “Tired of your pump running on empty?” the company wrote. “A significant proportion of insulin pump users have TDD requirements, whether due to insulin resistance, body weight, lifestyle, or […]
Dexcom to cease G6 CGM production next year, transition fully to G7
A Dexcom (NSDQ:DXCM) communication on its website states that it will soon cease manufacturing for its G6 continuous glucose monitor (CGM). After July 1, 2026, the company plans to no longer manufacture the G6, its previous-generation CGM. This marks a transition to the company’s latest-generation G7, and perhaps an eventual look ahead to future CGMs. […]
Modular Medical prices $4.7M public offering
Modular Medical (Nasdaq:MODD) announced that it priced an underwritten public offering of common stock worth approximately $4.68 million. The San Diego-based insulin pump maker intends to offer nearly 12.2 million shares of common stock and accompanying warrants to purchase nearly 6.1 million shares. Each two-share package is being offered and sold together with one accompanying […]
